Troy Cox

Troy Cox

Country

United States

Occupation

Business

Description

Board member of SomaLogic, Biosplice Therapeutics, Sophia Genetics, StandardBio Tools, and LetsGetChecked. Former President and CEO of Foundation Medicine from early 2017 through the acquisition by Roche valuing FMI at $5.3 billion. Former Senior Vice President and Officer at Genentech; leading U.S. Before Genentech, he held executive and senior roles of increasingly broad accountabilities including President of UCB BioPharmaceuticals, Senior Vice President of Sanofi-Aventis, and diverse foundational roles at Schering-Plough.

See Also

• LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies

Further Reading/Research

• https://www.linkedin.com/in/troy-cox-06708521/
• https://somalogic.com/team/troy-cox/
• https://www.globenewswire.com/en/news-release/2022/10/17/2535901/0/en/SomaLogic-Announces-the-Appointment-of-Biotech-Veteran-Troy-Cox-as-Executive-Chairman-of-the-Board-of-Directors.html

Share on Facebook

Tweet